These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1179442

  • 1. [Evaluation of various factors influencing the choice of therapy and the prognosis of the uterine corpus carcinoma].
    Merkas Z, Bekerus M, Parunović M, Trbojević P.
    Strahlentherapie; 1975 Aug; 150(2):121-6. PubMed ID: 1179442
    [Abstract] [Full Text] [Related]

  • 2. [Postoperative irradiation of carcinoma of the corpus uteri using the iridium afterloading technic].
    Kucera H, Weghaupt K.
    Strahlenther Onkol; 1988 Sep; 164(9):501-7. PubMed ID: 3175848
    [Abstract] [Full Text] [Related]

  • 3. [Adenocarcinoma of the endometrium. The role of vaginal brachytherapy in the therapeutic sequence].
    Calais G, Vitu L, Descamps P, Fignon A, Reynaud-Bougnoux A, Body G, Lansac J, Le Floch O.
    J Gynecol Obstet Biol Reprod (Paris); 1991 Sep; 20(1):101-6. PubMed ID: 2019710
    [Abstract] [Full Text] [Related]

  • 4. Prevention of vaginal recurrence of stage I endometrial adenocarcinoma with postoperative vaginal radiation.
    Marchetti DL, Piver MS, Tsukada Y, Reese P.
    Obstet Gynecol; 1986 Mar; 67(3):399-402. PubMed ID: 3945452
    [Abstract] [Full Text] [Related]

  • 5. Vaginal stump recurrence in carcinoma of the corpus uteri.
    Heyer E, Genau F.
    Zentralbl Gynakol; 1977 Mar; 99(2):81-4. PubMed ID: 848204
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Paraaortic lymph node radiotherapy in cancer of the uterine corpus.
    Potish RA, Twiggs LB, Adcock LL, Savage JE, Levitt SH, Prem KA.
    Obstet Gynecol; 1985 Feb; 65(2):251-6. PubMed ID: 3969238
    [Abstract] [Full Text] [Related]

  • 8. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base.
    Straughn JM, Numnum TM, Kilgore LC, Partridge EE, Phillips JL, Markman M, Thomas GM, Burke TW, Gynecologic Oncology Disease Site Team.
    Gynecol Oncol; 2005 Dec; 99(3):530-5. PubMed ID: 16198401
    [Abstract] [Full Text] [Related]

  • 9. [Surgical and radiotherapeutic treatment in stage I endometrial adenocarcinoma. Retrospective analysis of 218 patients].
    Latini P, Panizza BM, Checcaglini F, Maranzano E, Aristei C, Perrucci E.
    Radiol Med; 1989 Jun; 77(6):679-83. PubMed ID: 2756184
    [Abstract] [Full Text] [Related]

  • 10. [Radiotherapy of uterine cancer. A retrospective study].
    Banaschak A, Wever T, Schicke B.
    Zentralbl Gynakol; 1985 Jun; 107(17):1057-64. PubMed ID: 2414948
    [Abstract] [Full Text] [Related]

  • 11. [Efficiency of primary radiotherapy in generally or locally inoperable carcinoma of the endometrium].
    Kucera H, Michalica W, Weghaupt K.
    Osterr Z Onkol; 1977 Jun; 4(1):3-7. PubMed ID: 71675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W, DO V, Hogg R, Wain G, Brand A, Bull C, Stenlake A, Gebski V.
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [Abstract] [Full Text] [Related]

  • 14. [Radiotherapy of 4468 uterine carcinomas].
    Keller H, Nöcker D, Hering K, Soweidan S.
    Strahlentherapie; 1976 Mar; 151(3):208-13. PubMed ID: 1258091
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Radiotherapy of primary vaginal carcinoma and effects of histological and clinical factors on the prognosis].
    Vavra N, Seifert M, Kucera H, Weghaupt K.
    Strahlenther Onkol; 1991 Jan; 167(1):1-6. PubMed ID: 1992537
    [Abstract] [Full Text] [Related]

  • 18. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Fakiris AJ, Moore DH, Reddy SR, Look KY, Yiannoutsos CT, Randall ME, Cardenes HR, Hoosier Oncology Group.
    Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A, Weiss E, Hess CF.
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [Abstract] [Full Text] [Related]

  • 20. [The possibilities of optimal therapy of corpus uteri cancer (author's transl)].
    Kofler E, Kupka S, Kucera H, Michalica W, Weghaupt K.
    Wien Med Wochenschr; 1980 Sep 30; 130(18):590-4. PubMed ID: 7467373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.